loading
Precedente Chiudi:
$6.80
Aprire:
$6.79
Volume 24 ore:
111.62K
Relative Volume:
0.32
Capitalizzazione di mercato:
$348.90M
Reddito:
-
Utile/perdita netta:
$-19.90M
Rapporto P/E:
-12.75
EPS:
-0.53
Flusso di cassa netto:
$-19.80M
1 W Prestazione:
-0.26%
1M Prestazione:
-4.21%
6M Prestazione:
+60.11%
1 anno Prestazione:
+52.88%
Intervallo 1D:
Value
$6.65
$6.91
Intervallo di 1 settimana:
Value
$6.64
$7.178
Portata 52W:
Value
$3.19
$7.4899

Diamedica Therapeutics Inc Stock (DMAC) Company Profile

Name
Nome
Diamedica Therapeutics Inc
Name
Telefono
(763) 496-5454
Name
Indirizzo
301 CARLSON PARKWAY, MINNEAPOLIS, MN
Name
Dipendente
28
Name
Cinguettio
@diamedica
Name
Prossima data di guadagno
2025-03-17
Name
Ultimi documenti SEC
Name
DMAC's Discussions on Twitter

Confronta DMAC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
DMAC
Diamedica Therapeutics Inc
6.75 351.48M 0 -19.90M -19.80M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.16 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
629.15 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
424.92 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
837.09 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
184.56 39.72B 447.02M -1.18B -868.57M -6.1812

Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-30 Iniziato TD Cowen Buy
2024-10-07 Iniziato H.C. Wainwright Buy
2024-04-24 Ripresa Craig Hallum Buy
2023-06-22 Aggiornamento Oppenheimer Perform → Outperform
2021-04-09 Iniziato Oppenheimer Outperform
2021-02-17 Iniziato ROTH Capital Buy
2020-10-30 Iniziato Guggenheim Buy
2020-07-08 Iniziato Maxim Group Buy
2019-04-30 Iniziato Dougherty & Company Buy
2019-03-05 Iniziato Lake Street Buy
Mostra tutto

Diamedica Therapeutics Inc Borsa (DMAC) Ultime notizie

pulisher
09:33 AM

Why Wall Street Experts Believe This Biotech Stock Represents a Major Opportunity - Barchart.com

09:33 AM
pulisher
Nov 03, 2025

Will DiaMedica Therapeutics Inc. stock reach Wall Street targetsWeekly Market Outlook & Free Real-Time Volume Trigger Notifications - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Order flow analysis tools used on DiaMedica Therapeutics Inc.July 2025 Final Week & Reliable Volume Spike Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why DiaMedica Therapeutics Inc. stock remains on watchlistsMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will DiaMedica Therapeutics Inc. stock attract ESG investorsInsider Buying & AI Enhanced Trade Execution Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is DiaMedica Therapeutics Inc. stock supported by innovation pipeline2025 Macro Impact & AI Powered Market Trend Analysis - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Visual analytics tools that track DiaMedica Therapeutics Inc. performanceJuly 2025 Market Mood & Real-Time Buy Signal Notifications - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will breakout in DiaMedica Therapeutics Inc. lead to full recoveryJuly 2025 Levels & Low Drawdown Momentum Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is DiaMedica Therapeutics Inc. still worth holding after the dipMarket Activity Summary & Community Consensus Stock Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What momentum shifts mean for DiaMedica Therapeutics Inc.2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How DiaMedica Therapeutics Inc. stock performs in stagflationJuly 2025 Trends & Safe Investment Capital Preservation Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Has DiaMedica Therapeutics Inc. formed a bullish divergenceMarket Activity Recap & Precise Swing Trade Entry Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will DiaMedica Therapeutics Inc. stock outperform tech sector in 20252025 Dividend Review & Safe Capital Investment Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How institutional buying supports DiaMedica Therapeutics Inc. stock2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Developing predictive dashboards with DiaMedica Therapeutics Inc. dataEarnings Miss & Safe Swing Trade Setups - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Short interest data insights for DiaMedica Therapeutics Inc.Weekly Earnings Recap & Weekly Return Optimization Alerts - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Can DiaMedica Therapeutics Inc. stock hit analyst price targetsQuarterly Trade Report & AI Driven Stock Movement Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Using economic indicators to assess DiaMedica Therapeutics Inc. potentialPortfolio Profit Report & Weekly Stock Performance Updates - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is DiaMedica Therapeutics Inc. stock cheap at current valuation2025 Year in Review & Fast Moving Stock Trade Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Backtesting results for DiaMedica Therapeutics Inc. trading strategiesJuly 2025 Reactions & Free Reliable Trade Execution Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Smart tools for monitoring DiaMedica Therapeutics Inc.’s price actionCEO Change & Weekly Market Pulse Updates - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can DiaMedica Therapeutics Inc. stock double in next 5 years2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Can DiaMedica Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Published on: 2025-11-01 02:03:37 - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Coverage Initiated at TD Cowen - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Sector ETF performance correlation with DiaMedica Therapeutics Inc.Trade Risk Summary & Risk Controlled Stock Pick Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 05:34:37 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Live market analysis of DiaMedica Therapeutics Inc.Quarterly Trade Summary & Risk Managed Investment Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What valuation multiples suggest for DiaMedica Therapeutics Inc. stockJuly 2025 Drop Watch & Low Drawdown Trading Techniques - newser.com

Oct 31, 2025

Diamedica Therapeutics Inc Azioni (DMAC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Diamedica Therapeutics Inc Azioni (DMAC) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
STAHLBERG JAN
10% Owner
Aug 13 '25
Buy
5.91
293,601
1,734,918
7,058,066
STAHLBERG JAN
10% Owner
Aug 14 '25
Buy
5.99
70,414
421,921
7,128,480
STAHLBERG JAN
10% Owner
Aug 20 '25
Buy
5.86
71,107
416,495
7,207,820
STAHLBERG JAN
10% Owner
Aug 26 '25
Buy
6.00
59,648
357,888
7,713,693
STAHLBERG JAN
10% Owner
Aug 22 '25
Buy
5.96
59,788
356,576
7,315,780
STAHLBERG JAN
10% Owner
Aug 27 '25
Buy
6.00
50,772
304,632
7,764,465
STAHLBERG JAN
10% Owner
Aug 21 '25
Buy
5.96
48,172
287,028
7,255,992
STAHLBERG JAN
10% Owner
Aug 15 '25
Buy
6.00
8,233
49,398
7,136,713
STAHLBERG JAN
10% Owner
Jul 23 '25
Buy
3.50
1,542,857
5,400,000
6,764,465
Von Koch Thomas
10% Owner
Jul 23 '25
Buy
3.50
2,857,142
9,999,997
8,383,577
$37.76
price up icon 1.24%
$28.93
price up icon 0.85%
$102.27
price up icon 0.89%
$104.59
price up icon 0.62%
biotechnology ONC
$311.51
price up icon 0.01%
$184.56
price down icon 0.84%
Capitalizzazione:     |  Volume (24 ore):